Mc Coy Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 4.84 Cr
as on 19-12-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.75 Cr
as on 19-12-2024
- Satisfied Charges ₹ 4.70 Cr
as on 19-12-2024
- Revenue -62.64%
(FY 2021)
- Profit -81.73%
(FY 2021)
- Ebitda -10.25%
(FY 2021)
- Net Worth 0.15%
(FY 2021)
- Total Assets -28.72%
(FY 2021)
About Mc Coy Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.84 Cr.
The company currently has active open charges totaling ₹4.75 Cr. The company has closed loans amounting to ₹4.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rinamkumar Shah, Suken Shah, Mehul Choksi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2004PTC098840
- Company No.
098840
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mc Coy Drugs Private Limited offer?
Mc Coy Drugs Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Nervous System and Antipsychotic API, API (Active Pharmaceutical Ingredients), Antipyretic and Analgesic API, Chemical Intermediates, Acrylic Acid, Pantoprazole Drugs, Pantoprazole Sodium Injection, Caustic Soda, Caustic Soda Flakes.
Who are the key members and board of directors at Mc Coy Drugs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Choksi  | Director | 10-Feb-2016 | Current |
| Rinamkumar Shah | Director | 01-Jul-2004 | Current |
| Suken Shah | Director | 10-Feb-2016 | Current |
| Nihar Shah | Director | 30-Dec-2022 | Current |
Financial Performance of Mc Coy Drugs.
Mc Coy Drugs Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 62.64% decrease. The company also saw a substantial fall in profitability, with a 81.73% decrease in profit. The company's net worth moved up by a moderate rise of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mc Coy Drugs?
In 2021, Mc Coy Drugs had a promoter holding of 45.66% and a public holding of 54.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Slk-M Engineering & Consultants Private LimitedActive 4 years 4 months
Mehul Choksi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jul 2020 | ₹2.50 M | Open |
Tata Capital Financial Services Limited Creation Date: 18 Jul 2018 | ₹1.50 Cr | Open |
Others Creation Date: 04 Sep 2017 | ₹3.00 Cr | Open |
How Many Employees Work at Mc Coy Drugs?
Unlock and access historical data on people associated with Mc Coy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mc Coy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mc Coy Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
